Global  

Purdue Pharma

American pharmaceutical company

Purdue Pharma    ▸ Facts   ▸ Comments   ▸ News   ▸ Videos   

Purdue Pharma: American pharmaceutical company
Purdue Pharma L.P. is a privately held pharmaceutical company founded by John Purdue Gray. It is owned principally by members of the Sackler family as descendants of Mortimer and Raymond Sackler. In 2007, it paid out one of the largest fines ever levied against a pharmaceutical firm for mislabeling its product OxyContin, and three executives were found guilty of criminal charges. Although the company shifted its focus to abuse-deterrent formulations, Purdue continued to market and sell opioids as late as 2019, and continued to be involved in lawsuits around the opioid epidemic in the United States. Purdue filed for Chapter 11 bankruptcy protection on September 15, 2019 in New York.

0
shares
ShareTweetSavePostSend
 

OxyContin Maker Purdue Pharma to Plead Guilty to 3 Federal Charges [Video]

OxyContin Maker Purdue Pharma to Plead Guilty to 3 Federal Charges

Justice Department officials made the announcement on Wednesday.

Credit: Cover Video STUDIO     Duration: 01:19Published
OxyContin maker to plead guilty in opioid probe [Video]

OxyContin maker to plead guilty in opioid probe

Purdue Pharma agreed to plead guilty to criminal charges over the handling of its addictive prescription opioid OxyContin, in a deal that comes with a $8.4 billion settlement but stops short of..

Credit: Reuters Studio     Duration: 02:37Published
DOJ announces Purdue Pharma's plea deal in opioid probe [Video]

DOJ announces Purdue Pharma's plea deal in opioid probe

Purdue Pharma LP agreed to plead guilty to criminal charges over the handling of its addictive prescription opioid OxyContin, in a deal with U.S. prosecutors that imposed significant penalties..

Credit: Reuters Studio     Duration: 02:10Published
OxyContin maker nears guilty plea in opioid probe [Video]

OxyContin maker nears guilty plea in opioid probe

[NFA] Purdue Pharma, the OxyContin maker controlled by members of the wealthy Sackler family, is nearing an agreement to plead guilty to criminal charges as part of a broader deal to resolve U.S...

Credit: Reuters - Politics     Duration: 00:24Published

You Might Like


AP Top Stories Oct. 21 P

Here are the top stories for Wednesday, Oct 21st: Trump and Biden campaigns make October sprint; Justice Dept. announces Purdue Pharma settlement; Barrett visits senators on Capitol Hill; Pope Francis..
USATODAY.com - Published

Opioid crisis: OxyContin maker Purdue Pharma to plead to 3 criminal charges

opioid crisis: oxycontin maker purdue pharma to plead to 3 criminal charges
Drugmaker Purdue Pharma, the company behind the powerful prescription painkiller OxyContin that experts say helped touch off an opioid epidemic, will plead guilty to federal criminal charges as part of..
New Zealand Herald - Published Also reported by •USATODAY.com

Purdue Pharma to plead guilty in $8bn opioid settlement

The landmark deal with the US Department of Justice settles the most serious claims against the OxyContin-maker.
BBC News - Published

OxyContin maker to plead guilty to federal criminal charges in $8 billion settlement

Purdue Pharma, the company whose OxyContin painkiller that drove a nationwide opioid epidemic, has agreed to plead guilty to federal criminal charges as part of a settlement with the government that..
USATODAY.com - Published

Where the Purdue Pharma-Sackler legal saga stands

OxyContin maker Purdue Pharma LP and its controlling Sackler family have been negotiating with cities, counties and states on a proposed settlement worth an estimated $10 billion to resolve more than..
Reuters - Published

Exclusive: OxyContin maker Purdue is 'Pharma Co X' in U.S. opioid kickback probe - sources

OxyContin maker Purdue Pharma LP is the unnamed company that surfaced in criminal charging documents filed earlier this week in a probe of illegal kickbacks from drugmakers, according to people..
Reuters - Published

Sacklers withdrew over $10 billion in a decade from Purdue Pharma: New York Times

The Sackler family - owners of Purdue Pharma - transferred more than $10 billion in a decade from the OxyContin maker to its trusts and holding companies, the New York Times reported on Monday, citing..
Reuters - Published

Purdue Pharma’s Payments to Sacklers Soared Amid Opioid Crisis

A new audit finds that the family directed $10.7 billion from the drugmaker to family-controlled trusts and holding companies, as legal pressure tightened around Purdue.
NYTimes.com - Published

U.S. Supreme Court rejects Arizona opioid case against Purdue, Sackler family

The U.S. Supreme Court on Monday turned away a novel case by Arizona seeking to recover billions of dollars that the state has said that members of the Sackler family - owners of Purdue Pharma LP -..
Reuters - Published

Tufts University removes Sackler sign from bldg

A maintenance worker has used a hammer and a flexible wall scrapper to remove the name of the billionaire family that owns OxyContin maker Purdue Pharma from a Tufts University building. (Dec. 5)  
USATODAY.com - Published

Fake doctors: OxyContin maker thrives in China

OxyContin sales are slowing in the United States under an avalanche of lawsuits and the bankruptcy of Purdue Pharma. But the company's owner, the Sackler family, continues to profit from sales of their..
USATODAY.com - Published

OxyContin maker Purdue Pharma to pay states' lawyers, urged to help victims

OxyContin maker Purdue Pharma LP got court approval on Tuesday to reimburse millions of dollars in legal fees for states that back its proposed $10 billion settlement of opioid lawsuits, but with a..
Reuters - Published

Judge shields OxyContin-maker Purdue from litigation until April

Purdue Pharma LP and the company's Sackler family owners will be shielded until April 8, 2020, from sprawling opioid litigation to give the maker of OxyContin time to try to reach a legal settlement..
Reuters - Published

OxyContin maker Purdue gets brief shield from litigation

OxyContin maker Purdue Pharma LP won a court order on Friday briefly pausing the sprawling opioid litigation against the company so it can try to make headway on its proposed legal settlement that it..
Reuters - Published

Judge sees benefit in pausing lawsuits against OxyContin maker Purdue

A U.S. Bankruptcy Judge signaled support on Friday for a six-month pause to litigation led by 24 states against OxyContin maker Purdue Pharma LP to give the company time to settle thousands of lawsuits..
Reuters - Published

U.S. judge urges parties to wisely use Purdue opioid settlement funds

A U.S. bankruptcy judge on Thursday urged parties that will benefit from a proposed settlement with OxyContin maker Purdue Pharma LP to focus on addressing the opioid addiction crisis and avoid..
Reuters - Published

Cracks in Purdue's proposed opioid settlement as Arizona backs out

The U.S. state of Arizona withdrew its support for a proposed nationwide opioid settlement with Purdue Pharma LP, saying the maker of OxyContin sought to "undermine material terms of the deal,"..
Reuters - Published

Sacklers reaped up to $13 billion from OxyContin maker, U.S. states say

OxyContin maker Purdue Pharma LP steered up to $13 billion in profits to the company's controlling Sackler family, according to U.S. states opposing efforts to halt lawsuits alleging the company and..
Reuters - Published

U.S. states fight back against Purdue's bid to halt opioid lawsuits

U.S. state officials are due on Friday to launch a counterattack against OxyContin maker Purdue Pharma LP over its attempt to shield the company and its controlling Sackler family from thousands of..
Reuters - Published

Colleges got $60M-plus from OxyContin family

Prestigious universities around the world have accepted at least $60 million from the family that owns Purdue Pharma over the past five years.. (Oct. 3)  
USATODAY.com - Published

Purdue Pharma seeks to halt opioid suits against company, Sacklers

OxyContin maker Purdue Pharma LP on Wednesday asked a U.S. bankruptcy judge to halt for roughly nine months more than 2,600 lawsuits alleging the company and its controlling Sackler family helped fuel..
Reuters - Published

Purdue Pharma to stay in business as it pursues bankruptcy protection

Lawyers for the pharmaceutical company secured permission to maintain business as usual — paying employees and vendors, supplying pills to distributors and keeping current on taxes and insurance
CBS News - Published

Purdue bankruptcy hearing gets underway

A judge heard arguments to decide whether lawsuits against members of the Sackler family that owns Purdue Pharma can go ahead with the company seeking bankruptcy protection. (Sept. 17)  
USATODAY.com - Published

David Sackler defends family and Purdue Pharma

Vanity Fair contributing editor Bethany McClean joined CBSN to discuss her reporting on Purdue Pharma and its involvement in the opioid epidemic. She interviewed David Sackler, who says his family did..
CBS News - Published

Oxycontin maker Purdue begins bankruptcy in push to settle opioid lawsuits

OxyContin maker Purdue Pharma LP is expected in court on Tuesday to lay out its plan for using bankruptcy to resolve more than 2,600 lawsuits alleging the company fueled the U.S. opioid crisis.
Reuters - Published

What's next for OxyContin maker Purdue Pharma

OxyContin maker Purdue Pharma LP filed for bankruptcy protection after reaching a partial deal to resolve more than 2,600 lawsuits alleging it helped fuel the U.S. opioid crisis.
Reuters - Published

Purdue Pharma files for bankruptcy amid numerous lawsuits over opioid epidemic

Purdue Pharma, the company that made billions selling the prescription painkiller OxyContin, filed for bankruptcy late Sunday. The move came days after Purdue reached a tentative settlement with many..
CBS News - Published

Purdue Pharma files for bankruptcy. Here's what it means

Purdue Pharma is framing its bankruptcy filing as an opportunity to cut red tape and provide billions in settlement cash to curb the opioid crisis.
USATODAY.com - Published Also reported by •BBC NewsCBS News

In numbers: Sackler family, Purdue Pharma and the US opioid crisis

The controversial Sackler family has filed for bankruptcy, amid lawsuits from 2,600 plantiffs.
BBC News - Published

Even with bankruptcy, Purdue Pharma may not be off hook

Some states plan to object to a settlement in bankruptcy court and may pursue lawsuits against the Sackler family
CBS News - Published

OxyContin maker Purdue Pharma files for bankruptcy amid opioid crisis

OxyContin maker Purdue Pharma LP filed for bankruptcy protection Sunday night, succumbing to pressure from more than 2,600 lawsuits alleging the company helped fuel the deadly U.S. opioid epidemic.
France 24 - Published Also reported by •WorldNewsUSATODAY.comReuters

Your Monday Briefing

Iran, Purdue Pharma, Ric Ocasek: Here’s what you need to know.
NYTimes.com - Published

Sackler family 'funnelled $1bn into different bank accounts'

The family owns OxyContin-producer Purdue Pharma, which is accused of fuelling the US opioid crisis.
BBC News - Published

NY finds $1B in hidden transfers by family behind OxyContin

ny finds $1b in hidden transfers by family behind oxycontin
NEW YORK (AP) — The family that owns OxyContin maker Purdue Pharma used Swiss and other hidden accounts to transfer $1 billion to themselves, New York’s attorney general contends in court papers..
WorldNews - Published

New York Uncovers $1 Billion in Sackler Family Wire Transfers

In a court filing, the state attorney general’s office says that it has found new account transfers by family members who own Purdue Pharma, the maker of opioids.
NYTimes.com - Published

Eye Opener: The Trump administration moves to ban most flavored e-cigarettes

President Trump proposes a ban on most flavored vaping products. Also, 23 states have reached a tentative settlement with OxyContin maker Purdue Pharma over the nation’s opioid crisis. All that and..
CBS News - Published

Purdue Pharma 'reaches tentative agreement' to settle opioid cases

The manufacturer of painkiller OxyContin stands accused of helping fuel a deadly US crisis.
BBC News - Published



 Page 1  〉